← Leaderboards
Ali Shilatifard
Saint Louis University
$28,483,881
Attributed
$30,181,889
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,181,889 · 10
By mechanism
R01$17,093,531 · 5
R35$9,745,667 · 1
U54$1,975,000 · 1
T32$858,921 · 1
R21$426,006 · 1
P30$82,764 · 1
Top collaborators
- Judd F Hultquist2 shared
- Joshua James Meeks1 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularComplexBiochemicalLeukemiaPathogenesisBasePropertyChromatinMalignant NeoplasmsCellsGene Expression RegulationGenesHistonesMethylationProteinsMll GeneFamilyYeastsRegulationLaboratoriesEpigenetic ProcessHematologic NeoplasmsReagentChildhood Leukemia
Grant awards (62)
Somatic Truncation Mutations of the Histone Methyltransferase MLL4 Alter Its Subcellular Localization in Bladder Cancer: Mechanistic Insight and Targeted Therapeutic Approach$2,970,010
R01 · FY2025 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$939,694
R35 · FY2025 · CA · contact PI
Epigenetics, Metabolism and Cancer$344,170
T32 · FY2025 · CA · contact PI
Cancer Epigenetics and Nuclear Dynamics$82,764
P30 · FY2025 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$903,468
R35 · FY2024 · CA · contact PI
Epigenetics, Metabolism and Cancer$352,520
T32 · FY2024 · CA · contact PI
Exploring Small Molecule Inhibitors of PAF1C as Novel HIV Latency Reversal Agents$193,003
R21 · FY2024 · AI
Mutations of Chromatin and its Modifying Machineries in Malignancies$927,430
R35 · FY2023 · CA · contact PI
Exploring Small Molecule Inhibitors of PAF1C as Novel HIV Latency Reversal Agents$233,003
R21 · FY2023 · AI
Epigenetics, Metabolism and Cancer$162,231
T32 · FY2023 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$945,019
R35 · FY2022 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$919,663
R35 · FY2021 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$919,663
R35 · FY2020 · CA · contact PI
Transcriptional Elongation Control in Development and Disease$378,789
R01 · FY2020 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$797,082
R35 · FY2019 · CA · contact PI
Transcriptional Elongation Control in Development and Disease$379,200
R01 · FY2019 · CA · contact PI
Transcriptional Elongation Control in Development and Disease$367,425
R01 · FY2019 · CA · contact PI
Understanding and Targeting Wild-Type SS18 Function and Stability in Synovial Sarcoma$1,975,000
U54 · FY2018 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$919,663
R35 · FY2018 · CA · contact PI
Transcriptional Elongation Control in Development and Disease$380,472
R01 · FY2018 · CA · contact PI
Transcriptional Elongation Control in Development and Disease$378,789
R01 · FY2018 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$919,663
R35 · FY2017 · CA · contact PI
Transcriptional Elongation Control in Development and Disease$380,472
R01 · FY2017 · CA · contact PI
Transcriptional Elongation Control in Development and Disease$378,789
R01 · FY2017 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$919,663
R35 · FY2016 · CA · contact PI
Transcriptional Elongation Control in Development and Disease$375,458
R01 · FY2016 · CA · contact PI
Mutations of Chromatin and its Modifying Machineries in Malignancies$634,659
R35 · FY2015 · CA · contact PI
The COMPASS family of H3K4 methylases in development and cancer$490,235
R01 · FY2015 · CA · contact PI
Chromatin Modifications by Histone Ubiquitination and Methylations$414,179
R01 · FY2015 · GM · contact PI
Dot 1 Complex, Transcriptional Elongation Control and Human Cancer$249,040
R01 · FY2015 · CA · contact PI
Chromatin Modifications by Histone Ubiquitination and Methylations$389,337
R01 · FY2014 · GM · contact PI
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia$347,572
R01 · FY2014 · CA · contact PI
The COMPASS family of H3K4 methylases in development and cancer$261,777
R01 · FY2014 · CA · contact PI
Dot 1 Complex, Transcriptional Elongation Control and Human Cancer$248,605
R01 · FY2014 · CA · contact PI
Chromatin Modifications by Histone Ubiquitination and Methylations$26,127
R01 · FY2014 · GM · contact PI
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia$437,606
R01 · FY2013 · CA · contact PI
Chromatin Modifications by Histone Ubiquitination and Methylations$426,272
R01 · FY2013 · GM · contact PI
Dot 1 Complex, Transcriptional Elongation Control and Human Cancer$240,917
R01 · FY2013 · CA · contact PI
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia$465,538
R01 · FY2012 · CA · contact PI
Chromatin Modifications by Histone Ubiquitination and Methylations$441,732
R01 · FY2012 · GM · contact PI
Dot 1 Complex, Transcriptional Elongation Control and Human Cancer$256,294
R01 · FY2012 · CA · contact PI
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia$465,540
R01 · FY2011 · CA · contact PI
Chromatin Modification by Histone Ubiquitination and Methylations$420,832
R01 · FY2011 · GM · contact PI
Dot 1 Complex, Transcriptional Elongation Control and Human Cancer$302,100
R01 · FY2011 · CA · contact PI
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia$479,935
R01 · FY2010 · CA · contact PI
Chromatin Modification by Histone Ubiquitination and Methylations$425,216
R01 · FY2010 · GM · contact PI
Chromatin Modification by Histone Ubiquitination and Methylations$417,141
R01 · FY2009 · GM · contact PI
Physiological Role of MLL and ELL Proteins in Leukemia$256,294
R01 · FY2009 · CA · contact PI
Chromatin Modification by Histone Ubiquitination and Methylations$405,130
R01 · FY2008 · GM · contact PI
Physiological Role of MLL and ELL Proteins in Leukemia$256,294
R01 · FY2008 · CA · contact PI
Chromatin Modification by Histone Ubiquitination$356,663
R01 · FY2007 · GM · contact PI
Physiological Role of MLL and ELL Proteins in Leukemia$256,294
R01 · FY2007 · CA · contact PI
Chromatin Modification by Histone Ubiquitination$249,405
R01 · FY2006 · GM · contact PI
Physiological Role of MLL and ELL Proteins in Leukemia$244,027
R01 · FY2006 · CA · contact PI
Chromatin Modification by Histone Ubiquitination$77,637
R01 · FY2006 · GM · contact PI
Chromatin Modification by Histone Ubiquitination$307,885
R01 · FY2005 · GM
Physiological Role of MLL and ELL Proteins in Leukemia$249,900
R01 · FY2005 · CA
Chromatin Modification by Histone Ubiquitination$310,797
R01 · FY2004 · GM
Physiological Role of MLL and ELL Proteins in Leukemia$231,525
R01 · FY2004 · CA
Physiological Role of MLL and ELL Proteins in Leukemia$231,525
R01 · FY2003 · CA
Physiological Role of MLL and ELL Proteins in Leukemia$231,656
R01 · FY2002 · CA
Physiological Role of MLL and ELL Proteins in Leukemia$233,100
R01 · FY2001 · CA